Growth HormoneModerate Evidence

Hexarelin

Also known as: Examorelin

Potent hexapeptide ghrelin mimetic with strong GH-releasing effects and cardioprotective properties.

Benefits

6

Conditions

5

Evidence

Clinical trials, preclinical cardioprotection research+ studies

Source

Synthetic hexapeptide ghrelin mimetic

Overview

Potent hexapeptide ghrelin mimetic with strong GH-releasing effects and cardioprotective properties.

Mechanism of Action

Binds GHS-R1a ghrelin receptor with high affinity, produces large GH pulses (greater than GHRP-6), also binds CD36 receptor for cardioprotection independent of GH, may desensitize with chronic use.

Key Benefits

  • Very potent GH release
  • Cardioprotective effects
  • Increased muscle mass
  • Enhanced recovery
  • Improved bone density
  • Neuroprotection

Clinical Applications

Growth hormone deficiencyMuscle wastingCardiac dysfunction (investigational)Age-related GH declineOsteoporosis

Dosing Guidelines

Subcutaneous injection

Typical Dose100-200 mcg
Frequency1-2 times daily
DurationCycles of 4-8 weeks (desensitization concern)

* Dosing should be individualized. Always consult with a qualified healthcare practitioner.

Research & Evidence

Evidence Level
Moderate
Studies

Clinical trials, preclinical cardioprotection research

Summary

Clinical trials demonstrate potent GH release. Unique cardioprotective effects via CD36 shown in preclinical models. Desensitization limits long-term continuous use.

Safety Information

Potential Side Effects

  • Increased hunger
  • Water retention
  • Cortisol elevation (mild)
  • Desensitization with prolonged use

Contraindications

  • Active cancer
  • Pregnancy
  • Breastfeeding

Interactions

  • Synergistic with GHRH analogs

Quick Facts

CategoryGrowth Hormone
SourceSynthetic hexapeptide ghrelin mimetic
Legal StatusResearch compound, not FDA approved
Gabriel Brain Score
83/ 100

Source Your Protocol

Our preferred peptide partner offers lab-tested, COA-verified peptides with optional physician oversight. Sourced from US-regulated facilities.